Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02043054
What this trial is testing

Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)

Who this might be right for
Type 2 Diabetes MellitusCardiovascular Disease
University of Leicester 90
Large-scale testing (Phase 3)Study completedNCT02735031
What this trial is testing

Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1Hypoglycemia
Radboud University Medical Center 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT06015893
What this trial is testing

Semaglutide Therapy for Alcohol Reduction (STAR)

Who this might be right for
AddictionAlcohol Use Disorder
National Institute on Drug Abuse (NIDA) 63
Testing effectiveness (Phase 2)Looking for participantsNCT07523633
What this trial is testing

Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use Disorder

Who this might be right for
Cannabis Use DisorderCannabis Use DisordersCannabis Abuse+2 more
Anders Fink-Jensen, MD, DMSci 100
Post-approval studies (Phase 4)UnknownNCT03444142
What this trial is testing

Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
University of Guadalajara 30
Not applicableStudy completedNCT03659461
What this trial is testing

Glucagon-like Peptide-1 Levels, Insulin Resistance and Insulin Sensitivity Index in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes MellitusPreDiabetes
National University of Malaysia 174
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07319286
What this trial is testing

Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes Mellitus

Who this might be right for
Menstrual IrregularitiesType1 Diabetes MellitusGlucagon-Like Peptide-1 Receptor Agonists+1 more
Ain Shams University 50
Large-scale testing (Phase 3)Looking for participantsNCT07284979
What this trial is testing

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

Who this might be right for
Obesity
Kailera 1,200
Not applicableStudy completedNCT04388059
What this trial is testing

Antrum Size, Glucagon-like Peptide 1 Levels and Glycemic Control After Sleeve Gastrectomy in Morbid Obese Diabetic Adolescents

Who this might be right for
Adolescent Obesity
Tanta University 18
Testing effectiveness (Phase 2)Study completedNCT00099580
What this trial is testing

PROCLAIM: Effect of AC2592 Administered by Continuous Subcutaneous Infusion in Subjects With Advanced Chronic Congestive Heart Failure

Who this might be right for
Congestive Heart Failure
AstraZeneca 61
Not applicableLooking for participantsNCT07457437
What this trial is testing

Function and Lean Mass Preservation With Resistance Exercise During a GLP-1RA Treatment

Who this might be right for
Muscle Mass and StrengthObesity & OverweightPhysical Function
University of Exeter 60
Early research (Phase 1)Study completedNCT06568731
What this trial is testing

Learn How Different Amounts of the Study Medicine Danuglipron Are Taken up Into the Blood in Otherwise Healthy Adults With Overweight or Obesity

Who this might be right for
Obesity
Pfizer 23
Testing effectiveness (Phase 2)Looking for participantsNCT07616037
What this trial is testing

Efficacy of a GLP-1/FGF21 Dual Agonist for Treating PCOS

Who this might be right for
PCOS (Polycystic Ovary Syndrome)
Shanghai Zhongshan Hospital 30
Not applicableNot Yet RecruitingNCT07444073
What this trial is testing

Assessing Biological Aging in a Real-World Medical Weight Loss Program Using the LinAge2 Clinical Clock

Who this might be right for
AgingObesity & Overweight
National University of Singapore 440
Testing effectiveness (Phase 2)Study completedNCT06737042
What this trial is testing

Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants

Who this might be right for
Obesity and Overweight
Gan and Lee Pharmaceuticals, USA 326
Not applicableStudy completedNCT00747383
What this trial is testing

How Improvement in Control of Diabetes Influences the Production of a Hormone Produced in the Gut Which Improves the Release and Action of Insulin.

Who this might be right for
Type 2 Diabetes Mellitus
The Royal Bournemouth Hospital 74
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07200622
What this trial is testing

Oral Semaglutide in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Imperial College London 60
Not applicableStudy completedNCT05177653
What this trial is testing

Separate and Combined Extrapancreatic Effects of the Incretin Hormones

Who this might be right for
Pancreatectomy; Hyperglycemia
University Hospital, Gentofte, Copenhagen 13
Not applicableStudy completedNCT01901861
What this trial is testing

Effect of the DPP-4 Inhibitor Sitagliptin on Islet Function After Mixed Meal in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Lund University 12
Post-approval studies (Phase 4)Looking for participantsNCT06792422
What this trial is testing

A Study Investigating Oral Semaglutide in People with Open-Angle Glaucoma

Who this might be right for
Primary Open Angle Glaucoma (POAG)Open-Angle GlaucomaGlaucoma
Glostrup University Hospital, Copenhagen 126
Next Page